Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

de Leon J, Susce MT, Murray-Carmichael E.

Mol Diagn Ther. 2006;10(3):135-51. Review.

PMID:
16771600
2.

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

de Leon J, Armstrong SC, Cozza KL.

Psychosomatics. 2006 Jan-Feb;47(1):75-85. Review.

PMID:
16384813
3.

DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping.

de Leon J, Susce MT, Johnson M, Hardin M, Maw L, Shao A, Allen AC, Chiafari FA, Hillman G, Nikoloff DM.

CNS Spectr. 2009 Jan;14(1):19-34.

PMID:
19169185
4.

Applications of CYP450 testing in the clinical setting.

Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA.

Mol Diagn Ther. 2013 Jun;17(3):165-84. doi: 10.1007/s40291-013-0028-5. Review.

5.
6.

AmpliChip CYP450 test: personalized medicine has arrived in psychiatry.

de Leon J.

Expert Rev Mol Diagn. 2006 May;6(3):277-86. Review.

PMID:
16706732
7.

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Zhou SF.

Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. Review.

PMID:
19817501
8.

Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study.

Dodgen TM, Hochfeld WE, Fickl H, Asfaha SM, Durandt C, Rheeder P, Drögemöller BI, Wright GE, Warnich L, Labuschagne CD, van Schalkwyk A, Gaedigk A, Pepper MS.

BMC Med Genet. 2013 Jan 29;14:20. doi: 10.1186/1471-2350-14-20.

9.

Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Desta Z, Zhao X, Shin JG, Flockhart DA.

Clin Pharmacokinet. 2002;41(12):913-58. Review.

PMID:
12222994
10.

Pharmacogenetics and psychopharmacotherapy.

Poolsup N, Li Wan Po A, Knight TL.

J Clin Pharm Ther. 2000 Jun;25(3):197-220. Review.

PMID:
10886465
11.

Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.

Luo HR, Aloumanis V, Lin KM, Gurwitz D, Wan YJ.

Am J Pharmacogenomics. 2004;4(6):395-401.

PMID:
15651900
13.

Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study.

Egger T, Dormann H, Ahne G, Pahl A, Runge U, Azaz-Livshits T, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K.

Drugs Aging. 2005;22(3):265-72.

PMID:
15813658
14.

Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers.

Steimer W, Zöpf K, von Amelunxen S, Pfeiffer H, Bachofer J, Popp J, Messner B, Kissling W, Leucht S.

Clin Chem. 2004 Sep;50(9):1623-33. Epub 2004 Jun 17.

15.

Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes (PBLs).

Kuhlmann JB, Wensing G, Kuhlmann J.

Int J Clin Pharmacol Ther. 2014 Feb;52(2):143-50. doi: 10.5414/CP201966.

PMID:
24361088
16.

Steady-state plasma concentrations of imipramine and desipramine in relation to S-mephenytoin 4'-hydroxylation status in Japanese depressive patients.

Koyama E, Tanaka T, Chiba K, Kawakatsu S, Morinobu S, Totsuka S, Ishizaki T.

J Clin Psychopharmacol. 1996 Aug;16(4):286-93.

PMID:
8835703
17.

Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.

Bathum L, Skjelbo E, Mutabingwa TK, Madsen H, Hørder M, Brøsen K.

Br J Clin Pharmacol. 1999 Sep;48(3):395-401.

18.

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.

Scott SA, Edelmann L, Kornreich R, Erazo M, Desnick RJ.

Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721.

PMID:
18240905
19.

Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

Zhou SF.

Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000.

PMID:
19902987
20.

Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.

van der Weide J, van Baalen-Benedek EH, Kootstra-Ros JE.

Ther Drug Monit. 2005 Aug;27(4):478-83.

PMID:
16044105

Supplemental Content

Support Center